1.
Evaluation the serum levels of T3, T4, TSH, Thyroglobulin and Galactin-3 in patients with benign and malignant thyroid tumors. Journal of Pharmaceutical Negative Results [Internet]. 2022 Sep. 16 [cited 2024 Jun. 14];13(3):559-71. Available from: https://pnrjournal.com/index.php/home/article/view/667